PLx Pharma (PLXP) PT Raised to $12 at JMP Securities, Following Clinical Update
Tweet
Share
E-mailGet Alerts PLXP Hot Sheet
Price: $0.09 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JMP Securities analyst Jason N. Butler raised the price target on PLx Pharma (NASDAQ: PLXP) to $12.00 (from $9.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Seiko Group Corp (8050:JP) PT Raised to JPY7,400 at Nomura/Instinet
- Old Dominion Freight Line (ODFL) PT Raised to $233 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
